key: cord-1005099-4tx23k64
authors: Al Omari, Ahmad; Al-ashqar, Ra'ed; Alabd alrhman, Rasha; Nuseir, Amjad; Allan, Hadeel; Alzoubi, Firas
title: Assessment of the harms and potential benefits of tracheostomy in COVID-19 patients: Narrative review of outcomes and recommendations
date: 2021-02-28
journal: Am J Otolaryngol
DOI: 10.1016/j.amjoto.2021.102972
sha: fb820bb76f2c6fd4cb25830286697ce1cefced1e
doc_id: 1005099
cord_uid: 4tx23k64

nan

Another study from Lombardy Region, Italy suggests that many patients needed intubation for at least 1-2 weeks and the intensive care unit (ICU) stay seems to be relatively long. [4] This actively led to an increase in the number of candidates for tracheostomy globally.

The estimated percentage of tracheostomies performed among patients with severe COVID-19 infection varies from 29.3% [5] to 36.1% [6] , 40.9% [7] and 53% [8] as reported in the literature.

Because of the nature of COVID-19 infection and its ability to affect multi-organs systems, a multidisciplinary team should handle the decision of tracheostomy on a case-by-case basis.

Weighing the risks and benefits for both patient and health care workers (HCW). The aim of this review is to reach a forthright statement on whether tracheostomy gives superior outcomes for COVID-19 patients who are ventilator-dependent or with a predicted prolonged intubation and if it improves their prognosis. We will also highlight evidence based guidelines and protocols for performing tracheostomy safely and effectively during the COVID-19 pandemic.

We reviewed the available literature with interest in assessing the harms and benefits of carrying out tracheostomies in patients who are candidates for this procedure. A total of 14 studies with 2541 participants were included in this review. Of these, 5 studies were conducted in the UK, 3 studies from Italy, 3 studies from the USA, one from China and 2 studies from Spain (of which one study [9] is a multicentre prospective observational study collecting data from the UK, Italy, China, Japan and Spain). 283 participants were excluded due to incomplete or missing follow up data. All studies but one reported the number of patients who had immediate or short term complications related to the procedure which was estimated to be 6.7 %. This figure is similar to the percentage of short-term tracheostomy related complications seen in non COVID-19 patients. [38] J o u r n a l P r e -p r o o f Moreover, the endotracheal tube itself may cause a variety of complications. It may damage the vocal cords if left in for more than 10 days, and it may cause subglottic stenosis and laryngeal granulomas as well as perioral pressure sores if intubation is prolonged. These issues may be avoided if tracheostomy is done. [23] [24] Not to mention the fact that prone-postioning used in the management of COVID-19 in the ICU can lead to upper airway edema (along with edema from COVID-19) which increases the propensity to laryngeal edema, hence precluding extubation, so airway protection by tracheostomy may be beneficial. [25] On the other hand, there are many general procedural and post procedural complications of tracheostomy that are well known, in COVID-19 patients and otherwise. These include bleeding, pneumothorax, false passage, tube dislodgment, stoma infection, air leak and vocal cord palsy. J o u r n a l P r e -p r o o f Furthermore, it is widely known that tracheostomies are aerosol generating procedures [26] , and as such, they pose a significant risk of SARS-CoV2 transmission to the surgeon and the team members within the operating theatre. Previous studies show that the risk of viral transmission from tracheostomy is second only to intubation [40] . Therefore, it is crucial to follow strict evidence based general and procedural guidelines when performing tracheostomy to reduce the risk of viral transmission to medical personnel. As highlighted above, these recommendations were due in a part to the possibility of viral transmission particularly to healthcare workers involved in performing this procedure or providing care for the patients afterwards. Therefore, deferring the procedure when feasible until the viral load potentially dropped off would decrease the risk of transmission.

In addition, the prognosis in critically ill COVID-19 patients seems to be bad, with some regions publishing alarmingly high ICU mortality rates that reached up to 78%, as in Wuhan, China, [30] despite the fact that other reports from Wuhan described lower ICU mortality rates of 16% [31] and 49% [32] along with studies from Italy, USA and UK reporting ICU mortality rates of 26% [33] , 39% [34] and 51.6% [35] respectively. As of yet the prognosis for severe COVID-19 patients requiring critical care is poorly understood, and some publications were released while a significant portion of patients remained in the ICU which may lead to an underestimation of the actual mortality rate.

With scarcity of data on the positive influence of early tracheostomy on the prognosis and the clinical course of the disease, many would prefer to delay the decision of tracheostomy until having better idea about the prognosis in each selected case, and to identify the patients who have a sufficient chance of survival. In this context , many adopted the worldwide recommendation for tracheostomy timing [12] [14] [36] .In fact, a recent study conducted by Volo et al. [16] found that the ICU mortality rate of non-tracheostomized patients was 35% compared to 18% in patients with tracheostomy, with two thirds of these tracheostomies being performed early.

However, others focused their efforts to establish an evidence-based statement on the safety and effectiveness of early tracheostomy and to prove its positive influence on the prognosis along with liberation of ventilators and sorely needed ICU beds. [ 

One significant study conducted by Queen Elizabeth Hospital Birmingham COVID-19 airway team indicates that tracheostomized patients exhibited better survival rate than the nontracheostomized after one month of follow up, and showed that early tracheostomies done within 14 days of intubation were associated with shorter duration on ventilators and reduced ICU stay.

Consequently they were able to gain approximately 448 bed days by performing 64 earlier tracheostomies. [10] Another article recently published in the Respiratory Care Journal [37] reviewed several guidelines and protocols from different institutions, which concluded that tracheostomy can be carried out safely as early as 7 days after intubation in COVID-19 positive patients without jeopardizing the safety of patients and healthcare workers.

So far, there was insufficient data to decide whether the location and technique of this procedure would affect the outcomes, although one study suggests that earlier MV weaning could be achieved in patients who underwent surgical open tracheostomies compared to percutaneous technique. [7] However, as we have highlighted previously, a multidisciplinary team should make the decision based on patient prognostic factors and institutional resources.

As evidenced above, it is widely known that tracheostomies are aerosol generating procedures, and as such, pose a significant risk of SARS-CoV2 transmission to the surgeon and the team members within the operating theatre. Therefore, regardless of the timing and setting of the J o u r n a l P r e -p r o o f procedure, it is crucial to follow strict evidence based general and procedural guidelines when performing tracheostomy to reduce the risk of viral transmission to medical personnel. Below we will highlight some of these guidelines and protocols.

The procedure must ideally be done in a negative pressure operating theatre, [ In order to reduce airflow through the surgical incision site, and by extension, aerosolization of viral particles, the endotracheal tube must be advanced until the cuff is distal to the site of tracheal window creation, followed by hyperinflation of the cuff. When performing the surgical incision to create the tracheal window, care must be taken to avoid damaging the endotracheal tubes cuff, and electrocautery should be avoided to reduce vapours. 

In our review, we aimed to elaborate the possible gain from performing tracheostomy for candidate COVID-19 patients and weighing the benefits with the complications and the risk of this procedure. We believe the evidence shown above shows that, given proper safety protocols and guidelines are followed, the benefits of tracheostomy (and specifically early tracheostomy) in appropriate candidates outweighs the risks to the patient and involved healthcare personnel. In actuality, more data is needed with a large scale randomized controlled trial (RCT) comparing the outcomes between patients who underwent tracheostomy with ICU patients who did not and evaluating the correlation of the timing or the technique with such outcomes.

J o u r n a l P r e -p r o o f Journal Pre-proof [9] Spain 1890* 429 1,461 12 (median) 60/1890

Breik O. et al. [10] UK 100 75 25 13.9 (mean) 13/100

Angel L. et al. [11] USA 98 98 0 10.6 (mean) 5/98

Yeung. et al. [ 

Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: A systematic review and Meta-analysis

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region

Tracheostomy, ventilatory wean, and decannulation in COVID-19 patients

Surgical Tracheostomies in COVID-19 Patients: Indications, Technique, and Results in a Second-Level Spanish Hospital. OTO Open

Challenges of tracheostomy in COVID-19 patients in a tertiary centre in inner city London

Safety of bedside surgical tracheostomy during COVID-19 pandemic: A retrospective observational study

Outcome of 1890 tracheostomies for critical COVID-19 patients: a national cohort study in Spain

Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study

Novel Percutaneous Tracheostomy for Critically Ill Patients With COVID-19

Outcomes after Tracheostomy in COVID-19 Patients

The Role of Tracheotomy and Timing of Weaning and Decannulation in Patients Affected by Severe COVID-19

Early Data From Case Series of Tracheostomy in Patients With SARS-CoV-2. Otolaryngology-Head and Neck Surgery

Tracheostomy in the coronavirus disease 2019 patient: evaluating feasibility, challenges and early outcomes of the 14-day guidance

Elective tracheostomy during COVID-19 outbreak: to whom, when, how? Early experience from Venice

Safe and effective management of tracheostomy in COVID-19 patients

Surgical tracheostomies in COVID-19 patients: A multidisciplinary approach and lessons learned

Weaning by Surgical Tracheostomy and Portable Ventilators Released ICU Ventilators During Coronavirus Disease 2019 Surge in London

Tracheostomy: epidemiology, indications, timing, technique, and outcomes. Respir Care

Early versus late tracheostomy for critically ill patients

Early versus late tracheostomy: a systematic review and meta-analysis. Otolaryngol Head Neck Surg

Laryngeal complications of COVID-19

Classification of aerosol-generating procedures: a rapid systematic review

Tracheostomy during SARS-CoV-2 pandemic: Recommendations from the New York Head and Neck Society

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Characteristics of and important lessons from the coronavirus disease, (COVID-19) outbreak in China: summary of a report of 72,314 cases from the chinese center for disease control and prevention

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic

Surgical strategy and optimal timing of tracheostomy in patients with COVID-19: Early experiences in Japan

Controversies in Tracheostomy for Patients With COVID-19: The When, Where, and How. Respir Care

TracMan Collaborators FT. Effect of Early vs Late Tracheostomy Placement on Survival in Patients Receiving Mechanical Ventilation: The TracMan Randomized Trial

Outcomes from intensive care in patients with COVID-19: a systematic review and metaanalysis of observational studies

Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak